<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Yayın:
Aerobic exercises recommendations and specifications for patients with COVID-19: a systematic review

Yükleniyor...
Küçük Resim

Tarih

Kurum Yazarları

Item type:Araştırmacı/Yazar,
Item type:Araştırmacı/Yazar,
ALAWNA, MOTAZ

Akademik Birimler

Akademik Birimler

Danışman

Editör

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Türü:

Yayıncı

VERDUCI PUBLISHER, VIA GREGORIO VII, ROME 186-00165, ITALY

DOI

10.26355/eurrev_202012_24211

Özet

OBJECTIVE: This review was conducted to systematically analyze the effects of aerobic exercise on immunological biomarkers to provide safe aerobic exercise recommendations and specifications for patients with COVID-19. MATERIALS AND METHODS: A systematic search was conducted through MEDLINE (PubMed), Science Direct, Web of Science, Scopus, Cochrane Library, and SciELO databases. The search included the following keywords “immune system”, “immune cell”, or “immune function”; “aerobic training”, “aerobic exercise”, or “physical activity”; “human” or “adult”; and “cytokine”, “killer cell”, “T cell”, “interleukin”, “lymphocyte”, “leukocyte” or “adhesion molecule”. RESULTS: Eleven studies met the inclusion and exclusion criteria of this search. The most used exercise prescriptions included walking, cycling, or running. The duration of exercise ranged from 18 to 60 min with an intensity of 55% to 80% of VO2max or 60%-80% of maximum heart rate. The frequency range was 1 to 3 times/week. The mainly increased immunological biomarkers included leukocytes, lymphocytes, neutrophils, monocytes, eosinophils, IL-6, CD16-56, CD16, CD4, CD3, CD8, and CD19. CONCLUSIONS: This review demonstrated that patients with COVID-19 should follow a regular program of aerobic exercise for 20-60 min. This program should be in the form of cycling or walking with an intensity of 55%-80% VO2max or 60%-80% of maximum heart rate. This program should be repeated 2-3 sessions/week. These previous parameters could safely enhance immune functions without producing any exhaustion.

Tanım

Dergi veya Seri

European Review for Medical and Pharmacological Sciences

ISSN

1128-3602

ISBN

Dergi veya Seri

European Review for Medical and Pharmacological Sciences

WOS Q Değeri

Scopus Q Değerine göre

Hacim

24

Sorun

24

Alıntı

Onay

Gözden geçir

Tamamlayıcı Bilgiler

Referans Gösteren

Haklar

info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivs 3.0 United States

Creative Commons lisansı

Aksi belirtilmedikçe, bu öğenin lisansı şu şekilde açıklanmıştır: info:eu-repo/semantics/openAccess

Araştırma Projeleri

Dergi Sayısı

Related Patent

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators